These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26974375)

  • 81. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release.
    Cervia D; Fiorini S; Pavan B; Biondi C; Bagnoli P
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):200-9. PubMed ID: 11882916
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
    Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
    Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
    Li G; Low PS
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1792-1798. PubMed ID: 25791453
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Design, synthesis and α-amylase inhibitory activity of novel chromone derivatives.
    Valentina P; Ilango K; Chander S; Murugesan S
    Bioorg Chem; 2017 Oct; 74():158-165. PubMed ID: 28802166
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Synthesis and evaluation of 6-hydroxy-7-methoxy-4-chromanone- and chroman-2-carboxamides as antioxidants.
    Lee H; Lee K; Jung JK; Cho J; Theodorakis EA
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2745-8. PubMed ID: 15911250
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Challenges with chromone as a privileged scaffold in drug discovery.
    Silva CFM; Batista VF; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Sep; 13(9):795-798. PubMed ID: 29985064
    [No Abstract]   [Full Text] [Related]  

  • 87. Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues.
    Beierle JM; Horne WS; van Maarseveen JH; Waser B; Reubi JC; Ghadiri MR
    Angew Chem Int Ed Engl; 2009; 48(26):4725-9. PubMed ID: 19266506
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Optimizing the Synthetic Route of Chromone-2-carboxylic Acids: A Step forward to Speed-Up the Discovery of Chromone-Based Multitarget-Directed Ligands.
    Cagide F; Oliveira C; Reis J; Borges F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31757041
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.
    Reis J; Gaspar A; Milhazes N; Borges F
    J Med Chem; 2017 Oct; 60(19):7941-7957. PubMed ID: 28537720
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A highly efficient metal-free selective 1,4-addition of difluoroenoxysilanes to chromones.
    Wang XY; Yang M; Zhou Y; Zhou J; Hao YJ
    Org Biomol Chem; 2023 Feb; 21(5):1033-1037. PubMed ID: 36625240
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Chemogenomics with protein secondary-structure mimetics.
    Marshall GR; Kuster DJ; Che Y
    Methods Mol Biol; 2009; 575():123-58. PubMed ID: 19727613
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Structure Revision of the Fungal Phytotoxin Cavoxin and of Its Corresponding Chroman-4-one Cavoxone by X-ray Crystallography.
    Tuzi A; Carbone M; Ciavatta ML; Evidente A
    J Nat Prod; 2024 Jul; 87(7):1888-1892. PubMed ID: 38967603
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Carbohydrate mimetics as potential drug candidates.
    Soengas RG
    Mini Rev Med Chem; 2012 Dec; 12(14):1433. PubMed ID: 23350648
    [No Abstract]   [Full Text] [Related]  

  • 94. Asymmetric synthesis of polysubstituted chiral chromans
    Tang CK; Feng KX; Xia AB; Li C; Zheng YY; Xu ZY; Xu DQ
    RSC Adv; 2018 Jan; 8(6):3095-3098. PubMed ID: 35541173
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Diastereo- and Enantioselective Syntheses of Trisubstituted Benzopyrans by Cascade Reactions Catalyzed by Monomeric and Polymeric Recoverable Bifunctional Thioureas and Squaramides.
    Andrés JM; Maestro A; Valle M; Valencia I; Pedrosa R
    ACS Omega; 2018 Dec; 3(12):16591-16600. PubMed ID: 31458291
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Chroman-4-one and chromone based somatostatin β-turn mimetics.
    Fridén-Saxin M; Seifert T; Malo M; da Silva Andersson K; Pemberton N; Dyrager C; Friberg A; Dahlén K; Wallén EA; Grøtli M; Luthman K
    Eur J Med Chem; 2016 May; 114():59-64. PubMed ID: 26974375
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
    Chagnault V; Lalot J; Murphy PV
    ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
    Ulysse LG; Chmielewski J
    Chem Biol Drug Des; 2006 Feb; 67(2):127-36. PubMed ID: 16492160
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Somatostatin sst4 ligands: chemistry and pharmacology.
    Crider AM; Witt KA
    Mini Rev Med Chem; 2007 Mar; 7(3):213-20. PubMed ID: 17346214
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Catechol: A minimal scaffold for non-peptide peptidomimetics of the i + 1 and i + 2 positions of the beta-turn of somatostatin.
    Mowery BP; Prasad V; Kenesky CS; Angeles AR; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
    Org Lett; 2006 Sep; 8(20):4397-400. PubMed ID: 16986909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.